Edition:
India

Carl Zeiss Meditec AG (AFXG.DE)

AFXG.DE on Xetra

120.80EUR
17 Jan 2020
Change (% chg)

€1.60 (+1.34%)
Prev Close
€119.20
Open
€119.90
Day's High
€121.10
Day's Low
€119.30
Volume
63,663
Avg. Vol
137,320
52-wk High
€121.10
52-wk Low
€71.25

Latest Key Developments (Source: Significant Developments)

Carl Zeiss Meditec FY EBIT At EUR 264.7 Mln
Friday, 6 Dec 2019 

Dec 6 (Reuters) - CARL ZEISS MEDITEC AG ::FY REVENUE OF EUR 1,459.3 MILLION, RESULTING IN AN INCREASE OF 13.9% (ADJUSTED FOR CURRENCY EFFECTS: +11.7%) COMPARED WITH SAME PERIOD OF PRIOR YEAR (PRIOR YEAR: EUR 1,280.9 MILLION).FY EARNINGS BEFORE INTEREST AND TAXES (EBIT) ROSE SIGNIFICANTLY, TO EUR 264.7 MILLION (PRIOR YEAR: EUR 197.1 MILLION).EXPECTS TO BE ABLE TO GROW FASTER THAN UNDERLYING MARKETS AGAIN IN FISCAL YEAR 2019/20.OUTLOOK 2019/20: EBIT MARGIN IS EXPECTED TO BE IN A RANGE FROM 17 TO 19 PERCENT.IN MEDIUM TERM, WANTS TO SECURE LEVEL OF EARNINGS ALREADY ACHIEVED AND GENERATE EBIT MARGIN THAT IS SUSTAINABLY ABOVE 18%.  Full Article

Carl Zeiss Meditec FY EBIT Up At EUR 264 Million
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Carl Zeiss Meditec AG ::DGAP-ADHOC: CARL ZEISS MEDITEC ACHIEVES EBIT MARGIN OF 18.1% IN FISCAL YEAR 2018/19.EBIT FOR FISCAL YEAR 2018/19 AMOUNTED TO APPROX. EUR 264 MILLION (PAST YEAR: EUR 197.1 MILLION), LEADING TO AN EBIT MARGIN OF 18.1%.SHORTFALL WAS CAUSED BY HIGHER OPERATING EXPENSES IN Q4 OF FISCAL YEAR 2018/19.  Full Article

Carl Zeiss 9-Month Revenue Up At 1.03 Billion Euros
Monday, 15 Jul 2019 

July 15 (Reuters) - CARL ZEISS MEDITEC AG ::IS AIMING FOR THE UPPER END OF ITS REVENUE FORECAST FOR THE CURRENT YEAR AND EXPECTS STRONG EARNINGS.9M REVENUE 1.028 BILLION EUR.EARNINGS BEFORE INTEREST AND TAXES (EBIT) IS EXPECTED TO AMOUNT TO AROUND EUR 184 MILLION AFTER NINE MONTHS (PREVIOUS YEAR: EUR 134.8 MILLION).EARNINGS PER SHARE GREW TO AROUND EUR 1.22 (PREVIOUS YEAR: EUR 0.92).NOW EXPECTS FY REVENUE AT UPPER END OF PREVIOUS FORECAST RANGE OF EUR 1,350 TO EUR 1,420 MILLION.DOES NOT EXPECT A FURTHER INCREASE IN EBIT MARGIN IN COMING FISCAL YEAR 2019/20.FY EBIT MARGIN IS EXPECTED TO EXCEED PREVIOUS FORECAST RANGE OF 15.0 % TO 17.5 %.  Full Article

Carl Zeiss Meditec: H2 EBIT Margin Rose To 16.5 Pct
Monday, 6 May 2019 

May 6 (Reuters) - Carl Zeiss Meditec AG ::EBIT MARGIN ALSO INCREASED, TO 16.5 PERCENT (PRIOR YEAR: 14.4 PERCENT).H2 EARNINGS BEFORE INTEREST AND TAXES (EBIT) INCREASED SIGNIFICANTLY TO EUR110.4M (PRIOR YEAR: EUR88.2M).COMPANY PROVIDES NEW OUTLOOK FOR FY 2018/19.WE EXPECT TO ACHIEVE SALES OF EUR 1,350 MILLION - EUR 1,420 MILLION FOR FULL YEAR.ADJUSTING OUR EXPECTATIONS FOR CURRENT FISCAL YEAR 2018/19 AND NOW EXPECT AN EBIT MARGIN BETWEEN 15.0 PERCENT TO 17.5 PERCENT.MID-TERM DEVELOPMENT OF EBIT MARGIN WILL BE REVIEWED AS PART OF PUBLICATION OF FINANCIAL RESULTS FOR 2018/19.  Full Article

Carl Zeiss Meditec Confirms Margin Target After Q1
Monday, 11 Feb 2019 

Feb 11 (Reuters) - Carl Zeiss Meditec AG ::Q1 EBIT 48.1 MILLION EUR VERSUS 38.9 MILLION EUR YEAR AGO.CONTINUED PROFITABLE GROWTH FOR CARL ZEISS MEDITEC IN FIRST THREE MONTHS OF 2018/19.IN FIRST THREE MONTHS OF FISCAL YEAR 2018/19 CARL ZEISS MEDITEC GENERATED REVENUE OF EUR323.6M, REPRESENTING AN INCREASE OF 9.8% (ADJUSTED FOR CURRENCY EFFECTS: +9.0%) COMPARED WITH SAME PERIOD OF PREVIOUS YEAR (PRIOR YEAR: EUR294.7M).SIGNIFICANT GROWTH WAS POSTED IN EMEA^11 REGION, PARTICULARLY IN ITS CORE MARKETS GERMANY, FRANCE AND SOUTHERN EUROPE.EARNINGS BEFORE INTEREST AND TAXES (EBIT) INCREASED SIGNIFICANTLY TO EUR48.1M (PRIOR YEAR: EUR38.9M).EBIT MARGIN ALSO INCREASED, TO 14.9% (PRIOR YEAR: 13.2%).FOR FISCAL 2018/19, WE ARE EXPECTING TO GROW AT LEAST AS FAST AS OUR MARKETS, WHICH IS CONFIRMED BY OUR BUSINESS PERFORMANCE IN LAST THREE MONTHS.WE ARE ALSO HOLDING TO OUR MARGIN TARGET.  Full Article

Carl Zeiss Meditec Q1 EBIT Up At EUR 48.1 Million
Monday, 14 Jan 2019 

Jan 14 (Reuters) - Carl Zeiss Meditec AG ::ACIEVES STRONG REVENUE AND EBIT GROWTH IN FIRST THREE MONTHS 2018/19.Q1 REVENUE 324 MILLION EUR.Q1 EBIT INCREASED SIGNIFICANTLY TO EUR 48.1 MILLION (PREV. YEAR EUR 38.9 MILLION).FOR FISCAL YEAR 2018/19, COMPANY STILL EXPECTS AN EBIT MARGIN BETWEEN 14% TO 16%.  Full Article

Carl Zeiss Meditec FY EBIT Up At EUR 197.1 Mln
Friday, 7 Dec 2018 

Dec 7 (Reuters) - Carl Zeiss Meditec AG ::FY REVENUE UP BY 7.6 PERCENT TO EUR1,280.9M (PRIOR YEAR: EUR1,189.9M).FY EARNINGS BEFORE INTEREST AND TAXES (EBIT) ROSE TO EUR197.1M (PRIOR YEAR: EUR180.8M).FY EBIT MARGIN REMAINED STABLE AT 15.4 PERCENT (PRIOR YEAR: 15.2 PERCENT).ANTICIPATES FURTHER GROWTH FOR FISCAL YEAR 2018/19, AT LEAST TO LEVEL OF UNDERLYING MARKETS.SEES EBIT MARGIN BETWEEN 14 PERCENT AND 16 PERCENT IN FISCAL YEAR 2018/19 AND IN MEDIUM TERM.  Full Article

Carl Zeiss Meditec 9-mth Revenue Up By Around 7% At EUR 926 million
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Carl Zeiss Meditec AG ::DGAP-ADHOC: CARL ZEISS MEDITEC INCREASES REVENUE BY AROUND 7% IN FIRST NINE MONTHS 2017/18 AND ADJUSTS REVENUE OUTLOOK.9M REVENUE 926 MILLION EUR.FOR FISCAL YEAR 2017/18, CARL ZEISS MEDITEC NOW EXPECTS REVENUE OF BETWEEN EUR 1,250 TO EUR 1,300 MILLION.AT THIS POINT IN TIME, FURTHER FINANCIAL INFORMATION IS NOT YET AVAILABLE.  Full Article

Carl Zeiss Meditec Sees FY Adj EBIT Margin At 14-16 Pct
Monday, 12 Feb 2018 

Feb 12 (Reuters) - Carl Zeiss Meditec AG ::DGAP-NEWS: CARL ZEISS MEDITEC AG STARTS NEW FISCAL YEAR 2017/18 WITH SOLID REVENUE GROWTH.Q1 ‍REVENUE INCREASED BY 5.3 PERCENT​.Q1 ‍REVENUE 294.7 MILLION EUROS.‍Q1 EBIT 38.9 MILLION EUROS.Q1 ‍ADJUSTED EBIT MARGIN 13.5 PERCENT.‍OBJECTIVE FOR FISCAL YEAR 2017/18 CONTINUES TO BE TO GROW AT AT LEAST SAME RATE AS UNDERLYING MARKET​.‍EBIT MARGIN IS EXPECTED TO BE WITHIN RANGE ALSO FORECAST FOR MEDIUM TERM, OF 14 TO 16 PERCENT ON AN ADJUSTED BASIS​.  Full Article